CAREFREE, Ariz., March 6, 2012 (GLOBE NEWSWIRE) -- Isaac Eliaz, M.D., M.S., L.Ac., distinguished medical doctor and researcher, presents Galectin-3 as a breakthrough biomarker for numerous life-threatening diseases. He also shared new research on the critical role of Modified Citrus Pectin (MCP) as the foremost Galectin-3 blocker. Dr. Eliaz's latest presentation was given to hundreds of integrative oncologists during the Oncology Association of Naturopathic Physician's 2012 Convention (OncANP).
OncANP is one of the largest naturopathic organizations with members who specialize in the treatment of cancer. A major focus of the association's mission is to provide advanced training in the practice of naturopathic oncology for its membership and by doing so to improve the quality of care and patient outcome.
"It's truly rewarding to share cutting edge research with the medical community, demonstrating Modified Citrus Pectin's ability to promote health and prevent disease," says Dr. Eliaz. Modified Citrus Pectin offers remarkable health benefits, which includes binding and blocking excess Galectin-3 molecules throughout the body.
Role of Galectin-3 Molecules
Galectin-3 is produced naturally by our bodies, but new research proves that elevated levels can lead to serious health conditions like heart disease, fibrosis and metastatic cancer. By binding to and blocking excess Galectin-3 molecules, Modified Citrus Pectin prevents Galectin-3 from wreaking havoc on our bodies. A new blood test that measures circulating levels of Galectin-3 as a risk factor in progressive heart failure is now approved by the FDA and covered by most health insurance. This test can also help to determine risks of damage in other organs, including the liver, lungs, brain, kidneys, and others, as well as the progression of cancer.
Versatile Health Benefits of MCP
Recent studies also demonstrate that Modified Citrus Pectin enhances immune function, and reduces galectin-3 expression and disease severity in kidney injury. MCP is also proven to remove lead, mercury, arsenic and cadmium, without reducing essential minerals. "When the toxic burden is high, I recommend a gentle, yet highly effective heavy metal detoxification program using Modified Citrus Pectin," says Dr. Eliaz.
In addition, groundbreaking new research proves Modified Citrus Pectin (MCP) works synergistically to inhibit aggressive cancer cell behavior, when combined with two of Dr. Eliaz's advanced poly-botanical formulas: one for breast health and one for prostate health. This study was presented at the last Experimental Biology meeting and is presently in press for publication.
"The findings are extremely promising! Researchers have shown that MCP, in combination with either the breast or prostate formula, significantly further inhibits the metastatic processes of adhesion and migration of breast and prostate cancer cells, in a dose dependant manner," says Dr. Eliaz.
Honokiol For Cancer, Antioxidant and Anxiety Support
Research presented during Dr. Eliaz's lecture shows Honokiol has multiple health benefits ranging from anti-cancer and anti-oxidant, to a calming effect. Honokiol is extracted from the bark of the Magnolia tree and is safe to use with conventional cancer therapies. It also works synergistically with Modified Citrus Pectin for increased anti-cancer support.
The new discoveries give Modified Citrus Pectin greater potential in the prevention and treatment of many serious health conditions for which there are currently limited or no treatments available. For more information on Modified Citrus Pectin and the Poly-Botanical Formulas, contact (707) 583-8622 or e-mail info@betterhealthpublishing.com.
About Better Health Publishing
Better Health Publishing (BHP) focuses on the publication of key works promoting health and wellness. BHP believes that education and accessible information are the core components of a healthy and sustainable society.
For Media Questions/Interviews with Dr. Isaac Eliaz, Contact:
Amy Pellegrini
Communications Specialist
Better Health Publishing
amy@dreliaz.org
(707) 583-8622
This information was brought to you by Cision http://www.cisionwire.com
http://www.cisionwire.com/better-health-publishing/r/breakthrough-cancer-research-presented-at-naturopathic-oncology-conference,c9227939